Q3 2005 Report:
20% sales growth, positive result

aap Implantate AG, a German medical technology company specialized in healing fractures, joint replacement, bone cements and biomaterials, reports third-quarter sales of EUR 3.3 million, up 20% on the previous year’s EUR 2.8 million, and earnings before interest and taxes of EUR 438,000 (previous year: EUR 16,000). Earnings before taxes were EUR 379,000 (previous year:  minus EUR 63,000).

In the first nine months of financial year 2005, aap sales totaled EUR 9.6 million, up 12% on the previous year’s EUR 8.6 million, and earnings before interest and taxes were EUR 522,000 (previous year: minus EUR 187,000). Earnings before taxes increased to EUR 377,000 (previous year: minus EUR 1.145 million).

In the third quarter, when sales are customarily lowest, aap reached significant milestones:

• The start of shipping for new large OEM orders in the bone cement segment
• The signing of a long-term distribution agreement in the bone cement segment with Biomet Deutschland
• The implementation of a 10% capital increase
• The acquisition of two companies in the biomaterials segment (contracts signed in October, initial consolidation in Q4 2005).

The growth and earnings forecast made by the Management Board issued at the beginning of the year (double-digit sales growth and profitable results) is again reconfirmed.